Cheng Du Sheng Nuo Biotec Co., Ltd.SSE: 688117

Report for Q1 2025

Apr 25, 2025 · Issued by Cheng Du Sheng Nuo Biotec Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 25, 2025

On 6ix: 6ix.com/news/report-for-q1-2025-395

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Cheng Du Sheng Nuo Biotec Co., Ltd. on 6ix

Earlier from Cheng Du Sheng Nuo Biotec

Announcement on Voluntary Disclosure of Earnings Preannouncement for Q1 2025Mar 31, 2025
Announcement on Preliminary Earnings Estimate for 2024Feb 28, 2025
Announcement on Results of Share Reduction by Shareholders with Over 5% SharesDec 27, 2024
Announcement on the Company and Actual Controllers Providing Guarantee for the Wholly-owned Subsidiary's Application for Bank Comprehensive Credit LineDec 11, 2024
Indicative Announcement on Change in Equity of Shareholders Holding More than 5% of SharesNov 1, 2024

Later from Cheng Du Sheng Nuo Biotec

Announcement on Resolution of the 2024 Annual General MeetingMay 16, 2025
Announcement on Implementation of Dividend Distribution for 2024Jun 9, 2025
Announcement on Voluntary Disclosure of 2025 Semi-annual Earnings PreannouncementJun 20, 2025
Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Exenatide InjectionJul 1, 2025
Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Ganirelix InjectionJul 23, 2025

All Cheng Du Sheng Nuo Biotec news releases

Follow Cheng Du Sheng Nuo Biotec into a list and get an email when it puts out news.

Follow Cheng Du Sheng Nuo Biotec